European recommendations on organisation of interventional care in acute stroke (EROICAS)
- PMID: 31008277
- PMCID: PMC6301238
- DOI: 10.1177/2396987316659033
European recommendations on organisation of interventional care in acute stroke (EROICAS)
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Cognard: Consultancies: Medtronic, Sequent, Codman, Microvention, Stryker. No other conflicts of interest reported. Fiehler: Jens Fiehler has received fees as consultant or lecturer from Acandis, Bayer, Boehringer-Ingelheim, Codman, Covidien, MicroVention, Penumbra, Philips, Sequent, Siemens and Stryker. Consultant for Codman, MicroVention. Lectures for Boehringer-Ingelheim, Covidien, and Penumbra. Funding to institution: MicroVention. Unrelated: Consultant for Acandis, Sequent, Stryker. Lectures for Bayer, Philips, Siemens. Funding to Institution: DFG, BMBF, BMWi. Gallitelli: None. Jansen: Olav Jansen was a co-author of SWIFT-Prime, and is a steering committee member of SITS Open. Kobayashi: Employment, consultancies, stock ownership: none. Honoraria: Procardia Medical sp. Z o.o./Microvention, Travel grants: ev3/Covidien/Medtronic, Balt Extrusion. Mazighi: Consultancies: Servier, Boehringer Ingelheim; travel or speaker honoraria: Covidien, Boehringer Ingelheim, Aztra Zeneca and Bayer. Muir: No personal conflicts of interest. Institutional conflicts of interest: Grants to support the PISTE trial from the Stroke Association, National Institute of Health Research Health Technology Assessment programme, and unrestricted grants from Covidien (Medtronic) and Codman, to the University of Glasgow. Intellectual conflict of interest: Co-PI of the PISTE trial. Schaller: None. Schellinger: Employment: none, consultancies: Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, Cerevast, Photothera, Covidien, stock ownership: none, honoraria Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, Cerevast, Photothera, Covidien, paid expert testimony: expert witness at German courts, patents or patent applications: none, travel grants: Biogen, Novartis, Genzyme, Boehringer Ingelheim, Bayer, Daiichi Sankyo, Serono.
Similar articles
-
European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS).Int J Stroke. 2016 Aug;11(6):701-16. doi: 10.1177/1747493016647735. Int J Stroke. 2016. PMID: 27462090 No abstract available.
-
European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage.Eur Stroke J. 2025 May 22:23969873251340815. doi: 10.1177/23969873251340815. Online ahead of print. Eur Stroke J. 2025. PMID: 40401775 Free PMC article.
-
European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke.Int J Stroke. 2015 Aug;10(6):941-9. doi: 10.1111/ijs.12579. Epub 2015 Jul 6. Int J Stroke. 2015. PMID: 26148223
-
Multisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, European Society of Minimally Invasive Neurological Therapy, and Society of Vascular and Interventional Neurology.Catheter Cardiovasc Interv. 2013 Aug 1;82(2):E52-68. doi: 10.1002/ccd.24862. Epub 2013 May 3. Catheter Cardiovasc Interv. 2013. PMID: 23640740 Review.
-
European Stroke Organisation recommendations to establish a stroke unit and stroke center.Stroke. 2013 Mar;44(3):828-40. doi: 10.1161/STROKEAHA.112.670430. Epub 2013 Jan 29. Stroke. 2013. PMID: 23362084 No abstract available.
Cited by
-
Expanding indications for endovascular thrombectomy-how to leave no patient behind.Ther Adv Neurol Disord. 2021 Mar 16;14:1756286421998905. doi: 10.1177/1756286421998905. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33796144 Free PMC article. Review.
-
Endovascular Thrombectomy Versus Bridging Thrombolysis: Real-World Efficacy and Safety Analysis Based on a Nationwide Registry Study.J Am Heart Assoc. 2021 Feb 2;10(3):e018003. doi: 10.1161/JAHA.120.018003. Epub 2021 Jan 26. J Am Heart Assoc. 2021. PMID: 33496186 Free PMC article.
-
Blood Pressure Management in Acute Ischemic Stroke.Curr Hypertens Rep. 2020 Dec 10;23(1):3. doi: 10.1007/s11906-020-01120-7. Curr Hypertens Rep. 2020. PMID: 33305339 Free PMC article. Review.
-
Site and Rate of Occlusive Disease in Cervicocerebral Arteries: A CT Angiography Study of 2209 Patients with Acute Ischemic Stroke.AJNR Am J Neuroradiol. 2017 May;38(5):868-874. doi: 10.3174/ajnr.A5123. Epub 2017 Mar 16. AJNR Am J Neuroradiol. 2017. PMID: 28302611 Free PMC article.
-
[Border areas of thrombectomy].Nervenarzt. 2021 Aug;92(8):762-772. doi: 10.1007/s00115-021-01138-5. Epub 2021 Jun 7. Nervenarzt. 2021. PMID: 34100125 Free PMC article. Review. German.
References
-
- Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20. - PubMed
-
- Campbell BC, Mitchell PJ, Kleinig TJ, et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018. - PubMed
-
- Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030. - PubMed
-
- Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306. - PubMed
-
- Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources